Skip to main content

GSA CAPITAL PARTNERS LLP

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1362033 LONDON, X0

Position in AUPH

as of Mar 31, 2026 · filed May 8, 2026
Position Value
$1,533,380
-$571,190 QoQ
Shares Held
103,467
-21.6% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AUPH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $104,909,103 across 164 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in AUPH

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,533,380 103,467
2025-12-31 $2,104,570 131,948
2025-09-30 $126,677 11,464
2025-06-30 $2,366,670 279,418
2025-03-31 $714,844 88,911
2024-12-31 $105,586 11,758
2024-09-30 $920,977 125,645
2024-06-30 $1,301,982 228,018
2024-03-31 $1,749,512 349,204
2023-12-31 $1,060,316 117,944
2023-06-30 $1,631,999 168,595
2021-09-30 $506,865 22,904